Pharmacokinetic–Pharmacodynamic Relationship: Problems
Drug Discovery: Overview
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmacogenomics: Identification of New Drug Targets
Structure-Activity Relationships and Drug Design
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 5, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
Jonatan Taminau1, Gert Thijs, Hans De Winter
1Silicos NV, Wetenschapspark 7, B-3590 Diepenbeek, Belgium. hans.dewinter@silicos.com
A new tool called Pharao uses Gaussian volumes to model molecular features for drug discovery. This approach improves the scoring and alignment of small molecules, aiding in virtual screening and ligand clustering.
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: